🔎 Trials Near Me

Home › Leucemia linfatica cronica › Florida

Studi clinici su Leucemia linfatica cronica nello stato di Florida

34 studi su Leucemia linfatica cronica cercano partecipanti presso sedi nello stato di Florida.

Città nello stato di Florida

Testo ufficiale dello studio (inglese)

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

  • Study Site 102, St. Petersburg
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07582432

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

  • GC2202 Study Site 103, St. Petersburg
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT05645107

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

  • Holy Cross Hospital, Fort Lauderdale
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT04269902

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

  • Moffitt Cancer Center, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06697184

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

  • Mayo Clinic Jacksonville, Jacksonville
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
  • Moffitt Cancer Center, Tampa
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07277231

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Mayo Clinic Jacksonville, Jacksonville
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
  • Tampa General Hospital Cancer Institute, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT05006716

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

  • Cleveland Clinic Florida, Weston
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06943872

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

  • Florida Oncology and Hematology, Fort Myers
  • Baptist Md Anderson Cancer Center, Jacksonville
  • Cleveland Clinic Florida, Weston
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06846671

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  • Mayo Clinic Jacksonville, Jacksonville
  • Cancer Specialists of North Florida, Jacksonville
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06973187

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  • Lynn Cancer Center at Boca Raton Regional Hospital ( Site 0063), Boca Raton
  • Clermont Oncology Center ( Site 0046), Clermont
  • Florida Cancer Specialists - South ( Site 7001), Fort Myers
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06136559

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

  • Clermont Oncology Center ( Site 5430), Clermont
  • Memorial Hospital West ( Site 5410), Pembroke Pines
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT05947851

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  • Cancer Specialists, LLC, Jacksonville
In reclutamentoFase 4
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07218341

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  • SSAK Partners, Coral Springs
  • Mayo Clinic - Jacksonville, Jacksonville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07648264

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  • University of Miami, Coral Gables
  • Florida Cancer Specialists, Sarasota
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07221500

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • H. Lee Moffitt Cancer Center, Tampa
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT03666000

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • Mayo Clinic, Jacksonville
  • Moffitt Cancer Center, Tampa
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT04588922

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • e altri 9
In reclutamentoFase 3
Età 65 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07321652

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
  • Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
  • Morton Plant Hospital, Clearwater
  • e altri 11
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT05334069

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

  • University of Miami, Coral Gables
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT07520006

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  • Florida Cancer Specialists, Fort Myers
  • Cancer Specialists of North Florida -St Augustine, Saint Augustine
  • Florida Cancer Specialists East, West Palm Beach
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT05254743

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • Mayo Clinic, Clinical Trials Referral Office, Jacksonville
In reclutamentoFase 1/2
Età da 13 a 90 · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT06533579

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • University of Miami, Miami
  • Florida Cancer Specialists, Sarasota
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 lug 2026 · NCT05131022

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

  • Mt Sinai Comprehensive Cancer Center, Miami Beach
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 giu 2026 · NCT07271667

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  • University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 mag 2026 · NCT06588478

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • ASCLEPES Research Centers, Weeki Wachee
In reclutamentoFase 1/2
Età da 12 a 95 · Tutti i sessi · Aggiornato il 15 apr 2026 · NCT04329728

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

  • Malcolm Randall V.A. Medical Center /ID# 267825, Gainesville
  • Cancer Specialists of North Florida - Jacksonville - AC Skinner Parkway /ID# 266713, Jacksonville
  • Mid Florida Hematology And Oncology Center /ID# 269159, Orange City
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 apr 2026 · NCT06428019

Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma

  • Moffitt Cancer Center, Tampa
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 apr 2026 · NCT07030400

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 mar 2026 · NCT07218510

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

  • Cancer Specialists, LLC, Jacksonville
  • Sylvester Comprehensive Cancer Center, Miami
  • Florida Cancer Specialists, Sarasota
In reclutamentoFase 4
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 mar 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

  • Sylvester Comprehensive Cancer Center, Miami
  • Florida Cancer Specialists, Sarasota
In reclutamentoFase 4
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 mar 2026 · NCT06876662

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Napa Research, Pompano Beach
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 feb 2026 · NCT05544019

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

  • Mayo Clinic in Florida, Jacksonville
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 feb 2026 · NCT06191887

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

  • Mount Sinai Comprehensive Cancer Center, Miami Beach
  • Moffitt Cancer Center, Tampa
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 dic 2025 · NCT05602363

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

  • Florida Cancer Specialists, Sarasota
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2025 · NCT05780034

Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.